Angiogenesis Assays for the Analysis of CCN Proteins

Methods Mol Biol. 2023:2582:295-308. doi: 10.1007/978-1-0716-2744-0_20.

Abstract

Angiogenesis, the process of generating new blood vessels from an existing vasculature, is essential in normal developmental processes such as endochondral ossification and in numerous kinds of pathogenesis including tumor growth. A part from the actin of angiogenic factor or antiangiogenic factor, it is still unknown at which stage of the angiogenic cascade these agents affect angiogenesis. Here, we describe methods for the use of cellular communication network factor/connective tissue growth factor (CTGF/CCN2) and CCN2-neutralizing antibody in the currently used principal angiogenesis assays, including those in vitro ones for the proliferation, migration, adhesion, and tube formation of endothelial cells and in vivo assays such as those utilizing type I collagen implantation and the chick chorioallantoic membrane (CAM). In addition, we introduce an autofluorescence imaging of blood vessels in the subcutaneous tumor xenograft mouse model. These assays can be applied to studies on roles of CCN proteins in tumor metastasis and development of treatment strategies targeting CCN proteins.

Keywords: Adhesion; Autofluorescence imaging of blood vessels; Cell proliferation; Migration; Tube formation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inducing Agents
  • Angiogenesis Inhibitors
  • Animals
  • Biological Assay
  • Chorioallantoic Membrane / blood supply
  • Connective Tissue Growth Factor / metabolism
  • Endothelial Cells* / metabolism
  • Humans
  • Mice
  • Neovascularization, Pathologic* / pathology

Substances

  • Connective Tissue Growth Factor
  • Angiogenesis Inducing Agents
  • Angiogenesis Inhibitors